These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 7022313

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Experiences with estramustinphosphate (Estracyt) in estrogen-resistant metastasizing prostatic cancer].
    Köller A, Lunglmayr G.
    Wien Med Wochenschr; 1983; 133(7):179-81. PubMed ID: 6868629
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Randomised, double-blind study of estramustine phosphate and leuprolide acetate.
    De la Grange AB.
    Prog Clin Biol Res; 1987; 243B():227-8. PubMed ID: 3116555
    [No Abstract] [Full Text] [Related]

  • 25. Estracyt--mode of action and clinical experience.
    Hedlund PO.
    Prog Clin Biol Res; 1987; 243B():215-9. PubMed ID: 3309981
    [No Abstract] [Full Text] [Related]

  • 26. Clinical results with estramustine phosphate (NSC-89199): a comparison of the intravenous and oral preparations.
    Nilsson T, JONSSON G.
    Cancer Chemother Rep; 1975; 59(1):229-32. PubMed ID: 1093671
    [Abstract] [Full Text] [Related]

  • 27. Treatment of advanced prostatic carcinoma with estramustine phosphate (Estracyt).
    Jönsson G, Högberg B, Nilsson T.
    Scand J Urol Nephrol; 1977; 11(3):231-8. PubMed ID: 339329
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Treatment of advanced estrogen-resistant cancer of the prostate with estramustine phosphate. A phase-2 study].
    Trykker HU.
    Ugeskr Laeger; 1985 Oct 14; 147(42):3310-2. PubMed ID: 4082315
    [No Abstract] [Full Text] [Related]

  • 31. Pharmacoclinical study of oral estramustine phosphate (Estracyt) in advanced carcinoma of the prostate.
    Müntzing J, Shukla SK, Chu TM, Mittelman A, Murphy GP.
    Invest Urol; 1974 Jul 14; 12(1):65-8. PubMed ID: 4835492
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Estracyt--clinical experiences.
    Nilsson T.
    Scand J Urol Nephrol Suppl; 1980 Jul 14; 55():135-8. PubMed ID: 6938016
    [Abstract] [Full Text] [Related]

  • 34. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
    Kalland T, Haukaas S.
    Invest Urol; 1981 May 14; 18(8):437-9. PubMed ID: 7228576
    [Abstract] [Full Text] [Related]

  • 35. [Treatment of advanced prostatic carcinoma using estramustinphosphate].
    Ferrer Roda J.
    Actas Urol Esp; 1983 May 14; 7(1):29-34. PubMed ID: 6192690
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate.
    Chisholm GD, O'Donoghue EP, Kennedy CL.
    Br J Urol; 1977 May 14; 49(7):717-20. PubMed ID: 339986
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.